{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:04:02Z","timestamp":1793754242610,"version":"4.6.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03154-8","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:58:01Z","timestamp":1774879081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Associations of eight insulin resistance-related indices and genetic risk with incident cardiometabolic multimorbidity among participants with hypertension: a large prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Shaowei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuanbing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"1","key":"3154_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"E Di Angelantonio","year":"2015","unstructured":"Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, et al. Association of Cardiometabolic Multimorbidity With Mortality. JAMA. 2015;314(1):52\u201360.","journal-title":"JAMA"},{"issue":"1","key":"3154_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12916-021-02126-x","volume":"19","author":"D Canoy","year":"2021","unstructured":"Canoy D, Tran J, Zottoli M, Ramakrishnan R, Hassaine A, Rao S, et al. Association between cardiometabolic disease multimorbidity and all-cause mortality in 2 million women and men registered in UK general practices. BMC Med. 2021;19(1):258.","journal-title":"BMC Med"},{"issue":"3","key":"3154_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/01.hjh.0000209973.67746.f0","volume":"24","author":"CM Lawes","year":"2006","unstructured":"Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006;24(3):423\u201330.","journal-title":"J Hypertens"},{"issue":"1","key":"3154_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12916-019-1339-0","volume":"17","author":"YV Chudasama","year":"2019","unstructured":"Chudasama YV, Khunti KK, Zaccardi F, Rowlands AV, Yates T, Gillies CL, et al. Physical activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study. BMC Med. 2019;17(1):108.","journal-title":"BMC Med"},{"key":"3154_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102991","volume":"114","author":"L Yang","year":"2026","unstructured":"Yang L, Zhang Z, Zhang J, Miao J, Zhang H, Du Y, et al. Stage-specific risk factors of cardiometabolic multimorbidity: A systematic review and meta-analysis from incidence to mortality. Ageing Res Rev. 2026;114:102991.","journal-title":"Ageing Res Rev"},{"issue":"9","key":"3154_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030584","volume":"9","author":"L Feng","year":"2019","unstructured":"Feng L, Jehan I, de Silva HA, Naheed A, Farazdaq H, Hirani S, et al. Prevalence and correlates of cardiometabolic multimorbidity among hypertensive individuals: a cross-sectional study in rural South Asia-Bangladesh, Pakistan and Sri Lanka. BMJ Open. 2019;9(9):e030584.","journal-title":"BMJ Open"},{"issue":"3","key":"3154_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024476","volume":"9","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang X, Shen P, Si Y, Liu X, Xu Z, et al. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study. BMJ Open. 2019;9(3):e024476.","journal-title":"BMJ Open"},{"issue":"3","key":"3154_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.pharmthera.2007.10.004","volume":"117","author":"MJ Chapman","year":"2008","unstructured":"Chapman MJ, Sposito AC. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Pharmacol Ther. 2008;117(3):354\u201373.","journal-title":"Pharmacol Ther"},{"key":"3154_CR9","first-page":"252","volume":"22","author":"AM Jonk","year":"2007","unstructured":"Jonk AM, Houben AJ, de Jongh RT, Sern\u00e9 EH, Schaper NC, Stehouwer CD. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology (Bethesda). 2007;22:252\u201360.","journal-title":"Physiology (Bethesda)"},{"key":"3154_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.","journal-title":"Metabolism"},{"issue":"1","key":"3154_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"3154_CR12","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1463-1326.2004.00446.x","volume":"7","author":"DE Rosenberg","year":"2005","unstructured":"Rosenberg DE, Jabbour SA, Goldstein BJ. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment. Diabetes Obes Metab. 2005;7(6):642\u201353.","journal-title":"Diabetes Obes Metab"},{"key":"3154_CR13","doi-asserted-by":"crossref","unstructured":"Brie AD, Christodorescu RM, Popescu R, Adam O, T\u00eerziu A, Brie DM. Atherosclerosis and Insulin Resistance: Is There a Link Between Them? Biomedicines. 2025;13(6).","DOI":"10.3390\/biomedicines13061291"},{"issue":"2","key":"3154_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.numecd.2009.07.007","volume":"20","author":"M Matsuda","year":"2010","unstructured":"Matsuda M. Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis. 2010;20(2):79\u201386.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"3154_CR15","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3154_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02571-x","volume":"24","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhou Y, Xu Y, Wang X, Zhou Z, Wu K, et al. Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts. Cardiovasc Diabetol. 2025;24(1):11.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23(1):134.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02961-9","volume":"24","author":"J Hu","year":"2025","unstructured":"Hu J, Shang C, Huang Y, Sun C, Zhang J. Insulin resistance-related indices, genetic risk, and the risk of cardiovascular disease in individuals with preclinical or clinical obesity: a large prospective cohort study in the UK Biobank. Cardiovasc Diabetol. 2025;24(1):407.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24(1):12.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12933-025-02854-x","volume":"24","author":"Y Yue","year":"2025","unstructured":"Yue Y, Li P, Sun Z, Murayama R, Li Z, Hashimoto K, et al. Association of novel triglyceride-glucose-related indices with incident stroke in early-stage cardiovascular-kidney-metabolic syndrome. Cardiovasc Diabetol. 2025;24(1):301.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02842-1","volume":"24","author":"K Liu","year":"2025","unstructured":"Liu K, Hu J, Huang Y, He D, Zhang J. Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a prospective cohort study of 282,920 participants in the UK Biobank. Cardiovasc Diabetol. 2025;24(1):277.","journal-title":"Cardiovasc Diabetol"},{"key":"3154_CR24","doi-asserted-by":"crossref","unstructured":"Lin Y, Tao J, Wang H, Guan H, Liu X, Dong X, et al. The association of C-reactive protein-triglyceride-glucose index with cardiometabolic multimorbidity in middle-aged and older adults: evidence from two cohort studies. Cardiovasc Diabetol. 2026.","DOI":"10.1186\/s12933-026-03109-z"},{"key":"3154_CR25","doi-asserted-by":"crossref","unstructured":"Li C, Luo X, Chen Y, Lin J, Gu S. Predictive value of an integrated insulin resistance and lipometabolic score for cardiometabolic multimorbidity in older adults: a UK cohort study. Cardiovasc Diabetol. 2026;25(1).","DOI":"10.1186\/s12933-025-03064-1"},{"key":"3154_CR26","doi-asserted-by":"crossref","unstructured":"Zheng W, Man Z, Ren Y, Li Y, Zhu X, Wang L, et al. Association of the triglyceride glucose-Chinese visceral adiposity index with incident cardiometabolic multimorbidity in middle-aged and older adults: a nationwide prospective cohort study. Cardiovasc Diabetol. 2026.","DOI":"10.1186\/s12933-026-03091-6"},{"issue":"1","key":"3154_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12933-025-03067-y","volume":"25","author":"H Lai","year":"2026","unstructured":"Lai H, Deng C, Liao C, Tian R, Liu K, Luo Z, et al. Joint assessment of insulin resistance surrogate indices and basal metabolic rate for primary prevention of cardiometabolic multimorbidity: evidence from the China Health and Retirement Longitudinal Study (2011\u20132020). Cardiovasc Diabetol. 2026;25(1):37.","journal-title":"Cardiovasc Diabetol"},{"key":"3154_CR28","doi-asserted-by":"crossref","unstructured":"He Q, Yu W, Rao X, Lin D, You Y, Yan L, et al. Association between the cumulative atherogenic index of plasma and cardiometabolic multimorbidity: the mediating effects of the TyG index and body mass index. Lipids Health Dis. 2026;25(1).","DOI":"10.1186\/s12944-026-02875-9"},{"key":"3154_CR29","doi-asserted-by":"crossref","unstructured":"Chen S, Lv T, Zhou J. Association between modified cardiometabolic index and cardiometabolic multimorbidity in middle-aged and older adults: evidence from two nationwide cohort studies. Sci Rep. 2026.","DOI":"10.1038\/s41598-026-41398-2"},{"key":"3154_CR30","doi-asserted-by":"crossref","unstructured":"Chen W, Wu D, Chen X. Dose-response relationship of the C-reactive protein-triglyceride-glucose index with incident cardiometabolic multimorbidity \u2012 A cohort study in middle-aged and elderly Chinese adults. Nutr Hosp. 2026.","DOI":"10.20960\/nh.06075"},{"issue":"1","key":"3154_CR31","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12933-025-02939-7","volume":"24","author":"X Ruan","year":"2025","unstructured":"Ruan X, Ling Y, Chen J, Xiang Y, Ruan H, Zhang W, et al. Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24(1):382.","journal-title":"Cardiovasc Diabetol"},{"key":"3154_CR32","doi-asserted-by":"publisher","first-page":"1694959","DOI":"10.3389\/fendo.2025.1694959","volume":"16","author":"R Zhang","year":"2025","unstructured":"Zhang R, Ma J, Wang L. Cardiometabolic multimorbidity in relation to the metabolic score for insulin resistance and creatinine-to-cystatin C ratio in a middle-aged and aged population. Front Endocrinol (Lausanne). 2025;16:1694959.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3154_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12944-025-02836-8","volume":"25","author":"F Zhang","year":"2025","unstructured":"Zhang F, Zhang B, Huang X, Wang Z, Wang J, Lan H, et al. Comparison of the TyG index, TyG-traditional obesity indices, and TyG-novel obesity indices: does increased complexity help in predicting cardiometabolic multimorbidity? Lipids Health Dis. 2025;25(1):33.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3154_CR34","doi-asserted-by":"publisher","first-page":"38060","DOI":"10.1038\/s41598-025-21850-5","volume":"15","author":"H Wang","year":"2025","unstructured":"Wang H, Zhang H, Zhang L, Zheng X, Yang M. Combined effects of insulin resistance and dyslipidaemia on cardiometabolic multimorbidity in Chinese middle-age and older adults: a longitudinal cohort study. Sci Rep. 2025;15(1):38060.","journal-title":"Sci Rep"},{"issue":"1","key":"3154_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13690-025-01762-6","volume":"83","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang H, Liu X, Zhang J. Improving cardiometabolic multimorbidity prediction with a composite obesity-TyG index: a study of middle-aged and older adults in CHARLS. Arch Public Health. 2025;83(1):271.","journal-title":"Arch Public Health"},{"issue":"12","key":"3154_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0339646","volume":"20","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li D, Yu J, Gao Y, Zhang W, Tang M. Association between triglyceride-glucose derived indices with cardiometabolic multimorbidity: Findings from the Atherosclerosis Risk in Communities study. PLoS ONE. 2025;20(12):e0339646.","journal-title":"PLoS ONE"},{"issue":"1","key":"3154_CR37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12933-025-02919-x","volume":"24","author":"L Lv","year":"2025","unstructured":"Lv L, Zhang P, Chen X, Gao Y. The association between triglyceride glucose-waist height ratio index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study. Cardiovasc Diabetol. 2025;24(1):358.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. 2025;24(1):257.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12933-025-02761-1","volume":"24","author":"L Zhou","year":"2025","unstructured":"Zhou L, Wang J, Zhou Z, Wang L, Guo Q, Zeng H, et al. Long-term dual-trajectories of TyG and LAP and their association with cardiometabolic multimorbidity in midlife: the CARDIA study. Cardiovasc Diabetol. 2025;24(1):198.","journal-title":"Cardiovasc Diabetol"},{"key":"3154_CR40","doi-asserted-by":"publisher","first-page":"1518840","DOI":"10.3389\/fnut.2025.1518840","volume":"12","author":"C Zhou","year":"2025","unstructured":"Zhou C, Zhang Y, Liu X, He C, Li S. Relationship of METS-IR with cardiometabolic multimorbidity in China: a nationwide longitudinal cohort study. Front Nutr. 2025;12:1518840.","journal-title":"Front Nutr"},{"key":"3154_CR41","doi-asserted-by":"publisher","first-page":"1511319","DOI":"10.3389\/fendo.2025.1511319","volume":"16","author":"B Wan","year":"2025","unstructured":"Wan B, Wang S, Hu S, Han W, Qiu S, Zhu L, et al. The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic multimorbidity. Front Endocrinol (Lausanne). 2025;16:1511319.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3154_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3764","volume":"40","author":"D Xiao","year":"2024","unstructured":"Xiao D, Sun H, Chen L, Li X, Huo H, Zhou G, et al. Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle-aged and older populations: Insights from the China health and retirement longitudinal study. Diabetes Metab Res Rev. 2024;40(1):e3764.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"3154_CR43","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1186\/s12889-025-24480-8","volume":"25","author":"M Yang","year":"2025","unstructured":"Yang M, Liu J, Shen S, Shen Q, Liu Y, Qian Y. The association between baseline and long-term status of metabolic score for insulin resistance index and the incidence of cardiometabolic multimorbidity. BMC Public Health. 2025;25(1):3626.","journal-title":"BMC Public Health"},{"issue":"1","key":"3154_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12933-026-03077-4","volume":"25","author":"T Jin","year":"2026","unstructured":"Jin T, Tang X, Han Y, Fan H, Qin Q, Jiang H, et al. Relationship between nine triglyceride-glucose-related indices and cardiometabolic multimorbidity incidence in patients with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2026;25(1):36.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR45","doi-asserted-by":"publisher","first-page":"33793","DOI":"10.1038\/s41598-025-01963-7","volume":"15","author":"G Muheiyati","year":"2025","unstructured":"Muheiyati G, Wang J, Chen X, Guan X, An H, Tao N. The correlation between different metabolic scores and the risk of cardiometabolic comorbidities in hypertensive patients. Sci Rep. 2025;15(1):33793.","journal-title":"Sci Rep"},{"issue":"1","key":"3154_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-025-02591-1","volume":"24","author":"C Li","year":"2025","unstructured":"Li C, Zhang Z, Luo X, Xiao Y, Tu T, Liu C, et al. The triglyceride-glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis. Cardiovasc Diabetol. 2025;24(1):47.","journal-title":"Cardiovasc Diabetol"},{"key":"3154_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.100996","volume":"22","author":"I Dakota","year":"2025","unstructured":"Dakota I, Huang W, Wijayanto MA, Nurhafizah A, Khairunnisa AR, Rachmayanti S, et al. Prognostic value of triglyceride-glucose index on predicting major adverse cardiovascular events in hypertensive patients: a systematic review and meta-analysis. Am J Prev Cardiol. 2025;22:100996.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"3154_CR48","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12933-025-02902-6","volume":"24","author":"X Zheng","year":"2025","unstructured":"Zheng X, Zhang W, Yang F, Wang L, Yu B, Liang B. Evaluative performance of TyG-ABSI versus traditional indices in relation to cardiovascular disease and mortality: evidence from the U.S. NHANES. Cardiovasc Diabetol. 2025;24(1):344.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR49","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12933-025-02873-8","volume":"24","author":"J Qiu","year":"2025","unstructured":"Qiu J, Li J, Xu S, Yang J, Zeng H, Zhang Y, et al. Triglyceride glucose-weight-adjusted waist index as a cardiovascular mortality predictor: incremental value beyond the establishment of TyG-related indices. Cardiovasc Diabetol. 2025;24(1):306.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12933-022-01560-2","volume":"21","author":"JS Yun","year":"2022","unstructured":"Yun JS, Jung SH, Shivakumar M, Xiao B, Khera AV, Won HH, et al. Polygenic risk for type 2 diabetes, lifestyle, metabolic health, and cardiovascular disease: a prospective UK Biobank study. Cardiovasc Diabetol. 2022;21(1):131.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"3154_CR51","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamacardio.2018.1717","volume":"3","author":"MA Said","year":"2018","unstructured":"Said MA, Verweij N, van der Harst P. Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study. JAMA Cardiol. 2018;3(8):693\u2013702.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"3154_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12933-024-02332-w","volume":"23","author":"C Li","year":"2024","unstructured":"Li C, Meng X, Zhang J, Wang H, Lu H, Cao M, et al. Associations of metabolic changes and polygenic risk scores with cardiovascular outcomes and all-cause mortality across BMI categories: a prospective cohort study. Cardiovasc Diabetol. 2024;23(1):231.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3154_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"1","key":"3154_CR54","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12933-022-01632-3","volume":"21","author":"H Xie","year":"2022","unstructured":"Xie H, Li J, Zhu X, Li J, Yin J, Ma T, et al. Association between healthy lifestyle and the occurrence of cardiometabolic multimorbidity in hypertensive patients: a prospective cohort study of UK Biobank. Cardiovasc Diabetol. 2022;21(1):199.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR55","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12916-025-04344-z","volume":"23","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Yang H, Lin R, Yu Y, Zhao M, Xi B. Accelerometer-derived, \u201cweekend warrior\u201d physical activity pattern and cardiovascular disease in individuals with hypertension: a prospective cohort study. BMC Med. 2025;23(1):506.","journal-title":"BMC Med"},{"issue":"2","key":"3154_CR56","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/dym276","volume":"37","author":"P Elliott","year":"2008","unstructured":"Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37(2):234\u201344.","journal-title":"Int J Epidemiol"},{"key":"3154_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsac141","author":"L He","year":"2022","unstructured":"He L, Ma T, Li J, Luo Y, Zhang G, Cheng X, et al. Adherence to a healthy sleep pattern and incidence of cardiometabolic multimorbidity among hypertensive patients: a prospective study of UK Biobank. Sleep. 2022. https:\/\/doi.org\/10.1093\/sleep\/zsac141.","journal-title":"Sleep"},{"issue":"7726","key":"3154_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139.","journal-title":"Nature"},{"key":"3154_CR59","doi-asserted-by":"crossref","unstructured":"Thompson DJ, Wells D, Selzam S, Peneva I, Moore R, Sharp K, et al. UK Biobank release and systematic evaluation of optimised polygenic risk scores for 53 diseases and quantitative traits. MedRxiv. 2022:2022.2006. 2016.22276246.","DOI":"10.1101\/2022.06.16.22276246"},{"issue":"5","key":"3154_CR60","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/MOL.0000000000000536","volume":"29","author":"K Chella Krishnan","year":"2018","unstructured":"Chella Krishnan K, Mehrabian M, Lusis AJ. Sex differences in metabolism and cardiometabolic disorders. Curr Opin Lipidol. 2018;29(5):404\u201310.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"3154_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10522-023-10067-6","volume":"25","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Yue R. Aging adipose tissue, insulin resistance, and type 2 diabetes. Biogerontology. 2024;25(1):53\u201369.","journal-title":"Biogerontology"},{"issue":"6","key":"3154_CR62","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2337\/dc12-1235","volume":"36","author":"K Kodama","year":"2013","unstructured":"Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, Butte AJ. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care. 2013;36(6):1789\u201396.","journal-title":"Diabetes Care"},{"issue":"1","key":"3154_CR63","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dci20-0053","volume":"44","author":"F Hill-Briggs","year":"2020","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social Determinants of Health and Diabetes: A Scientific Review. Diabetes Care. 2020;44(1):258\u201379.","journal-title":"Diabetes Care"},{"issue":"20","key":"3154_CR64","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.117.029652","volume":"137","author":"WM Schultz","year":"2018","unstructured":"Schultz WM, Kelli HM, Lisko JC, Varghese T, Shen J, Sandesara P, et al. Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions. Circulation. 2018;137(20):2166\u201378.","journal-title":"Circulation"},{"issue":"1 Suppl 1","key":"3154_CR65","first-page":"S207","volume":"48","author":"C Disease","year":"2025","unstructured":"Disease C, Management R. Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S207-s238.","journal-title":"Diabetes Care"},{"issue":"5","key":"3154_CR66","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jamaneurol.2023.0183","volume":"80","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Lv Y, Rong S, Sun T, Chen L. Physical frailty, genetic predisposition, and incident Parkinson disease. JAMA Neurol. 2023;80(5):455\u201361.","journal-title":"JAMA Neurol"},{"issue":"5","key":"3154_CR67","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jama.2019.9879","volume":"322","author":"I Lourida","year":"2019","unstructured":"Lourida I, Hannon E, Littlejohns TJ, Langa KM, Hypp\u00f6nen E, Kuzma E, et al. Association of Lifestyle and Genetic Risk With Incidence of Dementia. JAMA. 2019;322(5):430\u20137.","journal-title":"JAMA"},{"issue":"28","key":"3154_CR68","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1002\/sim.7340","volume":"36","author":"NR Cook","year":"2017","unstructured":"Cook NR, Demler OV, Paynter NP. Clinical risk reclassification at 10 years. Stat Med. 2017;36(28):4498\u2013502.","journal-title":"Stat Med"},{"issue":"8","key":"3154_CR69","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/aje\/kwae037","volume":"193","author":"A Bellavia","year":"2024","unstructured":"Bellavia A, Melloni GEM, Park JG, Discacciati A, Murphy SA. Estimating and presenting hazard ratios and absolute risks from a Cox model with complex nonlinear interactions. Am J Epidemiol. 2024;193(8):1155\u201360.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"3154_CR70","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/ije\/dym157","volume":"36","author":"MJ Knol","year":"2007","unstructured":"Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007;36(5):1111\u20138.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"3154_CR71","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2337\/dc23-1503","volume":"47","author":"K Zhu","year":"2024","unstructured":"Zhu K, Qian F, Lu Q, Li R, Qiu Z, Li L, et al. Modifiable Lifestyle Factors, Genetic Risk, and Incident Peripheral Artery Disease Among Individuals With Type 2 Diabetes: A Prospective Study. Diabetes Care. 2024;47(3):435\u201343.","journal-title":"Diabetes Care"},{"key":"3154_CR72","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev.psych.58.110405.085542","volume":"58","author":"DP MacKinnon","year":"2007","unstructured":"MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol. 2007;58:593\u2013614.","journal-title":"Annu Rev Psychol"},{"issue":"1","key":"3154_CR73","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12933-024-02494-7","volume":"23","author":"H Raeisi-Dehkordi","year":"2024","unstructured":"Raeisi-Dehkordi H, Thorand B, Beigrezaei S, Peters A, Rathman W, Adamski J, et al. The mediatory role of androgens on sex differences in glucose homeostasis and incidence of type 2 diabetes: the KORA study. Cardiovasc Diabetol. 2024;23(1):411.","journal-title":"Cardiovasc Diabetol"},{"issue":"15","key":"3154_CR74","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/sim.3618","volume":"28","author":"IR White","year":"2009","unstructured":"White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med. 2009;28(15):1982\u201398.","journal-title":"Stat Med"},{"issue":"1","key":"3154_CR75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12933-026-03075-6","volume":"25","author":"ZJ Niu","year":"2026","unstructured":"Niu ZJ, Liu ZA, Wei T, Dou M, Tian PX, Cui Y. Association between the combined c-reactive protein-triglyceride glucose index and hypertension with long-term stroke among cardiovascular-kidney-metabolic syndrome stages 0\u20133 population: a nationwide prospective cohort study. Cardiovasc Diabetol. 2026;25(1):55.","journal-title":"Cardiovasc Diabetol"},{"key":"3154_CR76","doi-asserted-by":"crossref","unstructured":"Gado M, Tsaousidou E, Bornstein SR, Perakakis N. Sex-based differences in insulin resistance. J Endocrinol. 2024;261(1).","DOI":"10.1530\/JOE-23-0245"},{"issue":"1","key":"3154_CR77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12933-023-02021-0","volume":"23","author":"J Kim","year":"2024","unstructured":"Kim J, Kim D, Bae HJ, Park BE, Kang TS, Lim SH, et al. Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke. Cardiovasc Diabetol. 2024;23(1):5.","journal-title":"Cardiovasc Diabetol"},{"key":"3154_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58010004","author":"AL Kurniawan","year":"2021","unstructured":"Kurniawan AL, Hsu CY, Chao JC, Paramastri R, Lee HA, Jallow AW. Association of two indices of insulin resistance marker with abnormal liver function tests: a cross-sectional population study in Taiwanese adults. Medicina (Kaunas). 2021. https:\/\/doi.org\/10.3390\/medicina58010004.","journal-title":"Medicina (Kaunas)"},{"key":"3154_CR79","doi-asserted-by":"publisher","first-page":"1570239","DOI":"10.3389\/fcvm.2025.1570239","volume":"12","author":"J Xie","year":"2025","unstructured":"Xie J, Pei X, Zhu S, Jiang W, Tang H, Wu D, et al. Association of triglyceride-glucose-related indices with adverse clinical outcomes in individuals with normal body mass index. Front Cardiovasc Med. 2025;12:1570239.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"3154_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.481","volume":"7","author":"A Hasan","year":"2024","unstructured":"Hasan A, Newaj A, Trisha AD, Hafsa JM, Mohanto NC, Ali N. Assessment of the Relationship Between Liver Enzymes and Cardiovascular Disease: A Study in Bangladeshi Adults. Endocrinol Diabetes Metab. 2024;7(2):e00481.","journal-title":"Endocrinol Diabetes Metab"},{"key":"3154_CR81","doi-asserted-by":"publisher","first-page":"1280185","DOI":"10.3389\/fpubh.2023.1280185","volume":"11","author":"Y Jin","year":"2023","unstructured":"Jin Y, Xu Z, Zhang Y, Zhang Y, Wang D, Cheng Y, et al. Serum\/plasma biomarkers and the progression of cardiometabolic multimorbidity: a systematic review and meta-analysis. Front Public Health. 2023;11:1280185.","journal-title":"Front Public Health"},{"issue":"11","key":"3154_CR82","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.3390\/cimb45110570","volume":"45","author":"M Veskovi\u0107","year":"2023","unstructured":"Veskovi\u0107 M, \u0160utulovi\u0107 N, Hrn\u010di\u0107 D, Stanojlovi\u0107 O, Macut D, Mladenovi\u0107 D. The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease-The Transition from an Adipocentric to Liver-Centric Approach. Curr Issues Mol Biol. 2023;45(11):9084\u2013102.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"3154_CR83","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2337\/dsi23-0013","volume":"37","author":"JP Nogueira","year":"2024","unstructured":"Nogueira JP, Cusi K. Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care. Diabetes Spectr. 2024;37(1):20\u20138.","journal-title":"Diabetes Spectr"},{"key":"3154_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172657","volume":"862","author":"BM Patel","year":"2019","unstructured":"Patel BM, Goyal RK. Liver and insulin resistance: New wine in old bottle!!! Eur J Pharmacol. 2019;862:172657.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"3154_CR85","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/jch.14720","volume":"25","author":"HC Chen","year":"2023","unstructured":"Chen HC, Tsai YH, Huang CC. Triglyceride glucose index and renal function decline in Han Chinese hypertensive patients. J Clin Hypertens (Greenwich). 2023;25(10):951\u20136.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"3154_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1038758","volume":"13","author":"J Dong","year":"2022","unstructured":"Dong J, Yang H, Zhang Y, Chen L, Hu Q. A high triglyceride glucose index is associated with early renal impairment in the hypertensive patients. Front Endocrinol (Lausanne). 2022;13:1038758.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3154_CR87","doi-asserted-by":"publisher","first-page":"1018083","DOI":"10.3389\/fmed.2022.1018083","volume":"9","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, Chen Y, Cai X, Cai L, Hong J, Luo Q, et al. The non-linear relationship between triglyceride-glucose index and risk of chronic kidney disease in hypertensive patients with abnormal glucose metabolism: A cohort study. Front Med (Lausanne). 2022;9:1018083.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"3154_CR88","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2427907","volume":"56","author":"X Xu","year":"2024","unstructured":"Xu X, Ma R, Zhang X, Guo H, Keerman M, Wang X, et al. Association between renal function trajectories and risk of cardiovascular disease: a prospective cohort study. Ann Med. 2024;56(1):2427907.","journal-title":"Ann Med"},{"key":"3154_CR89","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ijcard.2015.09.090","volume":"202","author":"TC Turin","year":"2016","unstructured":"Turin TC, Jun M, James MT, Tonelli M, Coresh J, Manns BJ, et al. Magnitude of rate of change in kidney function and future risk of cardiovascular events. Int J Cardiol. 2016;202:657\u201365.","journal-title":"Int J Cardiol"},{"issue":"12","key":"3154_CR90","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrneph.2016.145","volume":"12","author":"F Artunc","year":"2016","unstructured":"Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, H\u00e4ring HU. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016;12(12):721\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"3154_CR91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000479801","volume":"8","author":"A Whaley-Connell","year":"2017","unstructured":"Whaley-Connell A, Sowers JR. Insulin resistance in kidney disease: is there a distinct role separate from that of diabetes or obesity? Cardiorenal Med. 2017;8(1):41\u20139.","journal-title":"Cardiorenal Med"},{"issue":"1","key":"3154_CR92","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000542965","volume":"15","author":"L Lo Cicero","year":"2025","unstructured":"Lo Cicero L, Lentini P, Sessa C, Castellino N, D\u2019Anca A, Torrisi I, et al. Inflammation and Arterial Stiffness as Drivers of Cardiovascular Risk in Kidney Disease. Cardiorenal Med. 2025;15(1):29\u201340.","journal-title":"Cardiorenal Med"},{"issue":"1","key":"3154_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3154_CR95","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/bc.bc_32_24","volume":"11","author":"J Li","year":"2025","unstructured":"Li J, Zhao S, Zhang X, Fan M, Wan J, Lin R, et al. Association of Systemic Inflammatory Response Index with the cardiometabolic multimorbidity among US adults: A population-based study. Brain Circ. 2025;11(1):39\u201347.","journal-title":"Brain Circ"},{"key":"3154_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207711","author":"S Feij\u00f3o-Band\u00edn","year":"2020","unstructured":"Feij\u00f3o-Band\u00edn S, Arag\u00f3n-Herrera A, Mora\u00f1a-Fern\u00e1ndez S, Anido-Varela L, Taraz\u00f3n E, Rosell\u00f3-Llet\u00ed E, et al. Adipokines and inflammation: focus on cardiovascular diseases. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21207711.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3154_CR97","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1007\/s00125-021-05498-0","volume":"64","author":"C Kohlmorgen","year":"2021","unstructured":"Kohlmorgen C, Gerfer S, Feldmann K, Twarock S, Hartwig S, Lehr S, et al. Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus. Diabetologia. 2021;64(8):1834\u201349.","journal-title":"Diabetologia"},{"issue":"1","key":"3154_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61546-w","volume":"14","author":"J Li","year":"2024","unstructured":"Li J, Li W, Li L, Yang S, Zhao G, Li K. Association between blood groups and myocardial injury after non-cardiac surgery: a retrospective cohort study. Sci Rep. 2024;14(1):14028.","journal-title":"Sci Rep"},{"key":"3154_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1205475","volume":"10","author":"SK Masenga","year":"2023","unstructured":"Masenga SK, Kirabo A. Hypertensive heart disease: risk factors, complications and mechanisms. Front Cardiovasc Med. 2023;10:1205475.","journal-title":"Front Cardiovasc Med"},{"issue":"Suppl 1","key":"3154_CR100","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1016\/j.diabres.2007.01.071","volume":"77","author":"T Nishikawa","year":"2007","unstructured":"Nishikawa T, Kukidome D, Sonoda K, Fujisawa K, Matsuhisa T, Motoshima H, et al. Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. Diabetes Res Clin Pract. 2007;77(Suppl 1):S161\u20134.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"3154_CR101","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-2796.2007.01824.x","volume":"262","author":"PJ Grant","year":"2007","unstructured":"Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007;262(2):157\u201372.","journal-title":"J Intern Med"},{"issue":"8","key":"3154_CR102","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","volume":"24","author":"AI Vinik","year":"2001","unstructured":"Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet dysfunction in type 2 diabetes. Diabetes Care. 2001;24(8):1476\u201385.","journal-title":"Diabetes Care"},{"issue":"1 Pt 2","key":"3154_CR103","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/01.HYP.29.1.280","volume":"29","author":"Y Higashi","year":"1997","unstructured":"Higashi Y, Oshima T, Sasaki N, Ishioka N, Nakano Y, Ozono R, et al. Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension. Hypertension. 1997;29(1 Pt 2):280\u20135.","journal-title":"Hypertension"},{"key":"3154_CR104","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m131","volume":"368","author":"GD Batty","year":"2020","unstructured":"Batty GD, Gale CR, Kivim\u00e4ki M, Deary IJ, Bell S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ. 2020;368:m131.","journal-title":"BMJ"},{"issue":"7","key":"3154_CR105","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41562-023-01579-9","volume":"7","author":"T Schoeler","year":"2023","unstructured":"Schoeler T, Speed D, Porcu E, Pirastu N, Pingault JB, Kutalik Z. Participation bias in the UK Biobank distorts genetic associations and downstream analyses. Nat Hum Behav. 2023;7(7):1216\u201327.","journal-title":"Nat Hum Behav"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03154-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:02:31Z","timestamp":1778475751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03154-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3154"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03154-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Northwest Multi-center Research Ethics Committee (MREC reference: 21\/NW\/0157) provided ethical approval for the UK Biobank project. All participants gave informed consent before being recruited.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}